- Total Pro Portfolios with KOOL:
- Gartmore Micro Cap Equity Inst GMEIX
- show more
- Total Do-It-Yourself Portfolios with KOOL:
- Chris Sullivan Portfolio 1
- Ing JH
- anton babich Portfolio 1
- BioHealth Investor.com
- tonys picks
- repatriate2 Portfolio 1
- Vermeer Portfolio 1
- Top Stem Cell Stocks
- Batter Up!
- kristina
- tahoe Portfolio 1
- ryan berning Portfolio 1
- kool
- jaz358 Portfolio 1
- oooranooo Portfolio 1
- oldwarrior
- superdog Portfolio 1
- JKhorizon
- lmrtrader Portfolio 1
- clieu Portfolio 1
- Educational Experience in Speculation
- House of Holtzman
- davidho4 Portfolio 1
- cfeezor13 Portfolio 1
- Pierco's Speculative Growth Fund.
- gianna Portfolio 1
- stktrader Portfolio 1
- knits_seitnap Portfolio 1
- show more
- 56
- Stem Cell Stocks
- FREEWAY CAPITAL
- sliderul I
- ed gonzales Portfolio 1
- Current M7oaks
- shnidr Portfolio 1
- 2007 TG
- Stockerblog.com Stem Cell Stocks
- petekni Portfolio 1
- stockerblog.com Cord Blood Stocks
- SUPRATRADE- QUANTUM TRUST
- jstu Portfolio 1
- Big Kahuna
- Justme798 Portfolio 1
- Barron's Stem Cell Stocks
- chazhug Portfolio 1
- fm9628 Portfolio 1
- Playing Stem Cells
- greekinvestor Portfolio 1
- stewarg66 local portfolio ii
- StemCellPlays
- brudiver Portfolio 1
- baberuth
- lsimmons57 Portfolio 1
- Rubyred664
- Dream Days
- freeol
- Barron's Insider Purchases 10-03-2009
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:e vosnock |
Date:01 19 09 |
cheap |
|
Not yet rated
Rate now:
|
|
By:Magor Tom |
Date:09 08 07 |
Patent protected, leader in field, big backer and sales force. Product that is top of the line that works. |
|
Not yet rated
Rate now:
|
|
By:Calvin Glenn |
Date:08 28 07 |
Small stem cell pec play |
|
Not yet rated
Rate now:
|
|
By:Hexdek16 |
Date:06 19 07 |
Shares of ThermoGenesis are currently trading at compelling levels that could produce nice gains if the company receives FDA approvals and subsequently ramps up the sales of its umbilical cord blood stem cell processing machines and ancillary products. As the company moves toward profitability (expected in about a year), investors now have a chance to buy shares at a KOOL discount to insider purchases last May, when executive Philip Coelho and director Dr. Hubert Huckel snatched up 75,000 shares at around $4 per share. |
|
Not yet rated
Rate now:
|
|
By:Jamie Fitch |
Date:05 17 07 |
(will complete) |
|
Not yet rated
Rate now:
|
|
By:kleffman |
Date:05 16 07 |
Medical Device, potential |
|
Not yet rated
Rate now:
|
|
By:Barrons |
Date:05 05 07 |
"Distribution of device for extracting/storing stem cells." |
|
Not yet rated
Rate now:
|
|
By:stockerblog |
Date:03 15 07 |
cord blood processing systems |
|
Not yet rated
Rate now:
|
|
By:drollinger |
Date:03 14 07 |
bio stock |
|
Not yet rated
Rate now:
|
|
By:Pam |
Date:02 24 07 |
ThermoGenesis (KOOL) This California company designs, manufactures, and markets automated blood processing systems that facilitates the manufacture, preservation, and delivery of cell therapies. P/S 13.6. |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |








